Back to search

Belgium· BE-AMP-SAM591911-00

Regkirona 60 mg/ml

A regdanvimab product containing regdanvimab, registered in Belgium by Celltrion Healthcare Hungary. The same ATC class is registered in 6 of our 19 countries.

ATC J06BD06

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedRegkirona 60 mg/mlATCJ06BD06REGISTER NO.BE-AMP-SAM591911-00PACKS LISTED0CHECKEDSeptember 26, 2026

Where it is registered

Regdanvimab is registered in 6 of 19 countries.

Countries holding a registration under ATC J06BD06 (regdanvimab), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 4 of them publish a price we can compare per daily dose

Regdanvimab · ATC J06BD06

6 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Polandprice
  • Spainprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Regdanvimab
Manufacturer
Celltrion Healthcare Hungary
Country
Belgium (BE)
ATC code
J06BD06
ATC class
Regdanvimab
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f72509c4-994d-462d-9ee9-d37e344982cf
GET /v1/drugs/f72509c4-994d-462d-9ee9-d37e344982cf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentrate for solution for infusion",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Regkirona 60 mg/ml",
  "name_fr": "Regkirona 60 mg/ml",
  "name_nl": "Regkirona 60 mg/ml",
  "amp_code": "SAM591911-00",
  "strengths": [
    "60.0000",
    "60.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Regdanvimab",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Regdanvimab",
  "authorisation_numbers": [
    "EU/1/21/1597/001"
  ]
}

See everything about regdanvimab.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.